{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Gilead Sciences", "item": "https://www.patentleaderboard.com/company/gilead-sciences"}, {"@type": "ListItem", "position": 3, "name": "Kin S. Yang", "item": "https://www.patentleaderboard.com/inventor/fl:ki_ln:yang-49"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
KY

Kin S. Yang — 15 Patents

GSGilead Sciences: 14 patents #128 of 952Top 15%
Foster City, CA: #272 of 2,058 inventorsTop 15%
California: #40,789 of 386,348 inventorsTop 15%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Kin S. Yang has been granted 15 US patents while listed as an inventor at Gilead Sciences. The first was granted in 2020 and the most recent in November 2025. Kin S. Yang ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Kin S. Yang in Foster City, CA, US.

Patents per Year

Patents granted per year, 2020 to 2025Bar chart with a peak of 5 patents in 2024.peak 52020: 2 patents20202021: 1 patents20212023: 4 patents20232024: 5 patents20242025: 3 patents2025

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12471292 Phase-change memory structure and phase-change memory device including the same Cheol-kyoo Lee, Yong Deong Kang, Hajun SUNG, Dong-hoon Ahn 2025-11-11
12338233 PD-1/Pd-L1 inhibitors Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more 2025-06-24
12269812 PD-1/PD-L1 inhibitors Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more 2025-04-08
12139474 LPA receptor antagonists and uses thereof Barton W. Phillips, Doris T. Tang, Chandrasekar Venkataramani, Anna Zagorska 2024-11-12 $714,990,000
11999717 Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof Brian P. Bestvater, Zhimin Du, Julie Farand, Gregory Notte, Barton W. Phillips +4 more 2024-06-04 $207,190,000
11980609 LPA receptor antagonists and uses thereof Brian P. Bestvater, Joshua A. Kaplan, Megan E. Neubig, Anna Zagorska 2024-05-14 $435,007,000
11939318 LPA receptor antagonists and uses thereof Brian P. Bestvater, Joshua A. Kaplan, Barton W. Phillips, Anna Zagorska 2024-03-26 $240,166,000
11912686 LPA receptor antagonists and uses thereof Brian P. Bestvater, Julie Farand, Doris T. Tang 2024-02-27 $463,301,000
11702407 LPA receptor antagonists and uses thereof Barton W. Phillips, Doris T. Tang, Chandrasekar Venkataramani, Anna Zagorska 2023-07-18 $149,671,000
11584738 LPA receptor antagonists and uses thereof Brian P. Bestvater, Zhimin Du, Julie Farand, Joshua A. Kaplan, Barton W. Phillips +4 more 2023-02-21 $220,051,000
11555029 PD-1/PD-L1 inhibitors Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more 2023-01-17 $669,972,000
11548871 Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof Brian P. Bestvater, Zhimin Du, Julie Farand, Gregory Notte, Barton W. Phillips +4 more 2023-01-10 $214,003,000
10899735 PD-1/PD-L1 inhibitors Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more 2021-01-26 $775,784,000
10774071 PD-1/PD-L1 inhibitors Evangelos Aktoudianakis, Aesop Cho, Michael Graupe, Lateshkumar Thakorlal Lad, Paulo A. Machicao Tello +9 more 2020-09-15 $253,208,000
10710986 PD-1/PD-L1 inhibitors Evangelos Aktoudianakis, Aesop Cho, Zhimin Du, Michael Graupe, Lateshkumar Thakorlal Lad +13 more 2020-07-14 $847,542,000